Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
949.56B
Market cap949.56B
Price-Earnings ratio
43.91
Price-Earnings ratio43.91
Dividend yield
0.62%
Dividend yield0.62%
Average volume
3.16M
Average volume3.16M
High today
$1,015.66
High today$1,015.66
Low today
$993.66
Low today$993.66
Open price
$1,010.00
Open price$1,010.00
Volume
1.38M
Volume1.38M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $1,006.57, with a market capitalization of 949.56B. The stock trades at a price-to-earnings (P/E) ratio of 43.91 and offers a dividend yield of 61.8%.

As of 2026-03-04, Eli Lilly(LLY) stock has fluctuated between $993.66 and $1,015.66. The current price stands at $1,006.57, placing the stock +1.3% above today's low and -0.9% off the high.

Eli Lilly(LLY) shares are trading with a volume of 1.38M, against a daily average of 3.16M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

24/7 Wall St. 9m
Forget AI. This Biotech Stock's Taking Off Right Now

Forget AI. This Biotech Stock’s Taking Off Right Now Quick Read Nvidia (NVDA) and Eli Lilly (LLY, down 7% YTD, forward P/E under 30x) in $1B partnership. Eli...

Forget AI. This Biotech Stock's Taking Off Right Now
TipRanks 4h
Lilly’s Tirzepatide Fasting Study Targets Safety Questions Around Obesity Blockbuster

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study titled “A Study to Evaluate the Effect of Fasting Duration and Tempo...

TipRanks 19h
Ventyx Biosciences Shareholders Approve Merger With Eli Lilly

Ventyx Biosciences ( (VTYX) ) has issued an update. On January 7, 2026, Ventyx Biosciences, Inc. entered into a Merger Agreement with Eli Lilly and Company and...

Analyst ratings

79%

of 34 ratings
Buy
79.4%
Hold
17.6%
Sell
2.9%

More LLY News

The Motley Fool 1d
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

Eli Lilly's (LLY 1.09%) big problem is its success in the GLP-1 drug space. Its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs grew sales by 99% a...

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
TipRanks 1d
Lilly Advances Remternetug Testing in China, Extending Its Alzheimer’s Pipeline Reach

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled “A Study to Investigate the Safety, Tolerability,...

TipRanks 1d
Eli Lilly Advances New Oral Diabetes Drug In China: What Investors Should Watch

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study A Phase 1, Participant- and Investigator-Blind, Placebo-Controlled,...

Zacks 1d
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer
Simply Wall St 2d
Eli Lilly’s Obesity And CRISPR Advances Raise Questions On Valuation

Eli Lilly (NYSE:LLY) and Scribe Therapeutics reached a key milestone in their collaboration to develop in vivo CRISPR-based genetic medicines targeting neurolog...

Eli Lilly’s Obesity And CRISPR Advances Raise Questions On Valuation
The Motley Fool 2d
The Best Healthcare Stock to Invest $1,000 in Right Now

When you think "top-performing pharma stock," Eli Lilly may first come to mind. Yet while Lilly's shares have surged over the past few years, they've only gaine...

The Best Healthcare Stock to Invest $1,000 in Right Now
Nasdaq 2d
Buying This 1 Pharmaceutical Stock Today Could Make You a Multimillionaire Retiree

Key Points Eli Lilly's ongoing innovations could set the business up for a long time. The company also has a strong dividend program. 10 stocks we like bette...

Buying This 1 Pharmaceutical Stock Today Could Make You a Multimillionaire Retiree

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.